Objectives This study sought to estimate and compare the aggregate treatment benefit of
pharmacological therapy for heart failure (HF) with reduced ejection fraction. Background The …

… patients with heart failure [7,8]. In this systematic review and meta-analysis, we wanted to
investigate the association between heart failure with poor outcome in patients with COVID-19. …

Aims Sarcopenia has been found to be frequently associated with co‐morbidity among patients
with heart failure (HF). However, there remain insufficient data to accurately estimate the …

… assigned during or shortly after hospitalisation for heart failure, most patients included in this
meta-analysis had chronic ambulatory heart failure. All trials required evidence of increased …

Aim To determine the role of prediabetes in the incidence of heart failure (HF). Materials
and Methods We searched electronic databases (PubMed, Embase, Google Scholar and …

… primary endpoint in this meta-analysis. Secondary endpoints … for heart failure or cardiovascular
death, first hospitalisation for heart failure, recurrent hospitalisations for heart failure or …

… meta-analysis regarding the safety and efficacy of sodium-glucose co-transporter 2 (SGLT2)
inhibitors in patients with heart failure … evaluated in this meta-analysis is reassuring, yet …

… meta-analysis, PubMed, Scopus, and the Web of science databases were searched from
January 1, 2000, to December 31, 2018, using QOL and heart failure … , heart failure patients in …

… patients with heart failure regardless of ejection fraction is unknown. A patient-level pooled
meta-analysis of two trials testing dapagliflozin in participants with heart failure and different …

… therapy in heart failure (HF). While the underlying mechanisms for improvements may differ
between heart failure reduced ejection fraction (HFrEF) and heart failure preserved ejection …